Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker came out with a mostly better-than-expected 2025 forecast.
Shares of athletic apparel maker Under Armour rose in premarket trading Thursday after the company's third-quarter sales and adjusted profit topped estimates.